1. Home
  2. TEVA vs NTR Comparison

TEVA vs NTR Comparison

Compare TEVA & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • NTR
  • Stock Information
  • Founded
  • TEVA 1901
  • NTR N/A
  • Country
  • TEVA Israel
  • NTR Canada
  • Employees
  • TEVA N/A
  • NTR N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • NTR Agricultural Chemicals
  • Sector
  • TEVA Health Care
  • NTR Industrials
  • Exchange
  • TEVA Nasdaq
  • NTR Nasdaq
  • Market Cap
  • TEVA 23.7B
  • NTR 24.8B
  • IPO Year
  • TEVA N/A
  • NTR N/A
  • Fundamental
  • Price
  • TEVA $16.75
  • NTR $52.60
  • Analyst Decision
  • TEVA Strong Buy
  • NTR Buy
  • Analyst Count
  • TEVA 6
  • NTR 16
  • Target Price
  • TEVA $24.17
  • NTR $58.67
  • AVG Volume (30 Days)
  • TEVA 15.5M
  • NTR 2.4M
  • Earning Date
  • TEVA 01-29-2025
  • NTR 02-19-2025
  • Dividend Yield
  • TEVA N/A
  • NTR 4.11%
  • EPS Growth
  • TEVA N/A
  • NTR N/A
  • EPS
  • TEVA N/A
  • NTR 1.36
  • Revenue
  • TEVA $16,544,000,000.00
  • NTR $25,016,000,000.00
  • Revenue This Year
  • TEVA $5.31
  • NTR N/A
  • Revenue Next Year
  • TEVA $1.18
  • NTR $3.15
  • P/E Ratio
  • TEVA N/A
  • NTR $38.22
  • Revenue Growth
  • TEVA 4.40
  • NTR N/A
  • 52 Week Low
  • TEVA $12.51
  • NTR $43.70
  • 52 Week High
  • TEVA $22.80
  • NTR $60.87
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 35.64
  • NTR 57.08
  • Support Level
  • TEVA $16.08
  • NTR $49.38
  • Resistance Level
  • TEVA $17.63
  • NTR $55.10
  • Average True Range (ATR)
  • TEVA 0.54
  • NTR 1.43
  • MACD
  • TEVA 0.01
  • NTR -0.02
  • Stochastic Oscillator
  • TEVA 39.82
  • NTR 59.94

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Share on Social Networks: